MDT

96.72

+0.86%↑

146.35

-0.6%↓

VEEV

230.66

-2.38%↓

HQY

84.44

-1.23%↓

PHR.US

16.51

-3.73%↓

MDT

96.72

+0.86%↑

146.35

-0.6%↓

VEEV

230.66

-2.38%↓

HQY

84.44

-1.23%↓

PHR.US

16.51

-3.73%↓

MDT

96.72

+0.86%↑

146.35

-0.6%↓

VEEV

230.66

-2.38%↓

HQY

84.44

-1.23%↓

PHR.US

16.51

-3.73%↓

MDT

96.72

+0.86%↑

146.35

-0.6%↓

VEEV

230.66

-2.38%↓

HQY

84.44

-1.23%↓

PHR.US

16.51

-3.73%↓

MDT

96.72

+0.86%↑

146.35

-0.6%↓

VEEV

230.66

-2.38%↓

HQY

84.44

-1.23%↓

PHR.US

16.51

-3.73%↓

Начало・Списък с акции・Talphera Inc.

Talphera Inc.

Отворен

0.99 -1

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

0.96

Максимум

1.03

Ключови измерители
By Trading Economics
Служители	13

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+198.17% upside

Дивиденти
By Dow Jones
Следващи печалби	30.03.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-12M 49M
Предишно отваряне	1.99
Предишно затваряне	0.99

Talphera Inc. Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

12.01.2026 г., 23:54 ч. UTC

Пазарно говорене

CBA Could Underperform Again in 2026 -- Market Talk

12.01.2026 г., 23:48 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

12.01.2026 г., 23:48 ч. UTC

Пазарно говорене

Nikkei May Rise on Weaker Yen -- Market Talk

12.01.2026 г., 23:43 ч. UTC

Пазарно говорене

Gold Edges Lower on Likely Technical Correction -- Market Talk

12.01.2026 г., 23:18 ч. UTC

Придобивния, сливания и поглъщания

Paramount Sues Warner Bros., Plans Proxy Fight. The Ellisons Aren't Giving Up. -- Barrons.com

12.01.2026 г., 21:56 ч. UTC

Пазарно говорене

Light & Wonder Gets Positive Outcome From Lawsuit -- Market Talk

12.01.2026 г., 21:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

12.01.2026 г., 21:50 ч. UTC

Пазарно говорене

Health Care Roundup: Market Talk

12.01.2026 г., 21:50 ч. UTC

Пазарно говорене

Печалби

Auto & Transport Roundup: Market Talk

12.01.2026 г., 21:18 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

12.01.2026 г., 21:18 ч. UTC

Пазарно говорене

Pfizer CEO Sees Large Cash Market for Obesity Drugs -- Market Talk

12.01.2026 г., 20:54 ч. UTC

Печалби

Gap, Fortinet, and More Stocks That Usually Outperform After Earnings -- Barrons.com

12.01.2026 г., 20:48 ч. UTC

Пазарно говорене

Oil Futures Settle Higher in Choppy Trade -- Market Talk

12.01.2026 г., 20:33 ч. UTC

Пазарно говорене

U.S. Natural Gas Jumps on Colder Weather Outlook -- Market Talk

12.01.2026 г., 20:18 ч. UTC

Придобивния, сливания и поглъщания

Credit Agricole Sees Banco BPM Stake Helping 2025 Net by EUR200M >ACA.FR

12.01.2026 г., 20:18 ч. UTC

Придобивния, сливания и поглъщания

Credit Agricole: European Central Bank Approves Crossing of 20% Threshold in Share Capital of Banco BPM

12.01.2026 г., 19:39 ч. UTC

Пазарно говорене

J&J CEO: Trump Pact Allows Company to Focus on Core Operations -- Market Talk

12.01.2026 г., 19:36 ч. UTC

Пазарно говорене

Gold and Silver Set New Records on Fed Probe -- Market Talk

12.01.2026 г., 19:36 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

12.01.2026 г., 19:33 ч. UTC

Пазарно говорене

Venezuela's 'Proven' Oil Reserves Raises Questions -- Market Talk

12.01.2026 г., 19:24 ч. UTC

Придобивния, сливания и поглъщания

Dynavax: 'Party A' CEO Sent a Non-Binding $15/Shr Proposal on Dec. 23

12.01.2026 г., 19:22 ч. UTC

Придобивния, сливания и поглъщания

Dynavax Files Tender Offer Recommendation Statement Related to Sanofi Deal, Mentions Talks With 'Party A'

12.01.2026 г., 18:21 ч. UTC

Придобивния, сливания и поглъщания

Paramount Plans Proxy Fight to Push Hostile Warner Bid -- 2nd Update

12.01.2026 г., 18:20 ч. UTC

Придобивния, сливания и поглъщания

This French Biotech Stock Surged 1,700% in 2025. Eli Lilly Is Taking an Interest. -- Barrons.com

12.01.2026 г., 18:19 ч. UTC

Пазарно говорене

Modest Canadian Economic Impact Seen from Venezuela Changes -- Market Talk

12.01.2026 г., 18:16 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Comcast Could Unlock Value With a Spinoff of NBCUniversal Assets, Analysts Say -- Market Talk

12.01.2026 г., 18:09 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

12.01.2026 г., 18:09 ч. UTC

Пазарно говорене

Baidu's Outlook Bodes Well For Shares -- Market Talk

12.01.2026 г., 18:01 ч. UTC

Придобивния, сливания и поглъщания

QXO Is Raising Another $1.8 Billion for Its M&A War Chest -- Barrons.com

12.01.2026 г., 18:00 ч. UTC

Пазарно говорене

Canada's 'Breakeven' Employment Recalibrating -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Talphera Inc. Прогноза

Ценова цел

By TipRanks

198.17% нагоре

12-месечна прогноза

Среден 3.25 USD 198.17%

Висок 3.5 USD

Нисък 3 USD

Според 2 анализатори от Wall Street, предложили 12-месечна ценова цел за Talphera Inc. през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

2 ratings

Купи

Задържане

Продай

Според 2 анализатори, дали борсови рейтинги на Talphera Inc. през последните 3 месеца.

Финанси

Относно Talphera Inc.

Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is headquartered in San Mateo, California.